[go: up one dir, main page]

PE20091362A1 - Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen - Google Patents

Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen

Info

Publication number
PE20091362A1
PE20091362A1 PE2008002191A PE2008002191A PE20091362A1 PE 20091362 A1 PE20091362 A1 PE 20091362A1 PE 2008002191 A PE2008002191 A PE 2008002191A PE 2008002191 A PE2008002191 A PE 2008002191A PE 20091362 A1 PE20091362 A1 PE 20091362A1
Authority
PE
Peru
Prior art keywords
alkyl
gamma
hydroxy
lactone
carboxyl
Prior art date
Application number
PE2008002191A
Other languages
English (en)
Inventor
Klar Ulrich
Joachim Kuhnke
Rolf Bohlmann
Jan Huebner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Hans-Peter Muhn
Katja Prelle
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20091362A1 publication Critical patent/PE20091362A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)

Abstract

REFERIDA A UN DERIVADO DE GAMMA-LACTONA DEL ESTEROIDE DEL ACIDO 17-HIDROXI-19-NOR-21-CARBOXILICO DE FORMULA (I), DONDE Z ES OXIGENO, H, NOR', NNHSO2R'; R' ES H, ALQUILO C1-C10, ARILO O ARALQUILO C7-C20; R4 ES H O HALOGENO; R6a Y R6b SON H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R7 ES H, ALQUILO C1-C10, ALQUINILO C2-C10, CICLOALQUILO C3-C6, ENTRE OTROS; R15 ES H; R16a Y R16b SON H, ALQUILO C1-C10, ENTRE OTROS; R18 ES H O ALQUILO C1-C3. SON COMPUESTOS PREFERIDOS: GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7ALFA-METIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7BETA-METIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7ALFA-ETIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD GESTAGENICA Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS MENOPAUSICOS Y MOLESTIAS PREMENSTRUALES, ENTRE OTROS
PE2008002191A 2007-12-29 2008-12-29 Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen PE20091362A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063503A DE102007063503A1 (de) 2007-12-29 2007-12-29 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PE20091362A1 true PE20091362A1 (es) 2009-10-15

Family

ID=40481980

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002191A PE20091362A1 (es) 2007-12-29 2008-12-29 Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen

Country Status (22)

Country Link
US (1) US8937058B2 (es)
EP (1) EP2238151A1 (es)
JP (1) JP5600068B2 (es)
KR (1) KR20100102688A (es)
CN (1) CN101910190A (es)
AR (1) AR069966A1 (es)
AU (1) AU2008342910A1 (es)
BR (1) BRPI0821922A2 (es)
CA (1) CA2710491C (es)
CL (1) CL2008003918A1 (es)
CO (1) CO6300845A2 (es)
CR (1) CR11545A (es)
DE (1) DE102007063503A1 (es)
DO (1) DOP2010000198A (es)
EC (1) ECSP10010318A (es)
IL (1) IL206379A0 (es)
PA (1) PA8809701A1 (es)
PE (1) PE20091362A1 (es)
TW (1) TW200940073A (es)
UY (1) UY31584A1 (es)
WO (1) WO2009083266A1 (es)
ZA (1) ZA201005396B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US3194803A (en) * 1960-04-28 1965-07-13 Searle & Co Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3426771C2 (de) 1984-07-07 1997-03-20 Schering Ag 13alpha-Methylgonane, deren Herstellung und Verwendung
DE4232521A1 (de) 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Also Published As

Publication number Publication date
PA8809701A1 (es) 2009-07-23
CN101910190A (zh) 2010-12-08
IL206379A0 (en) 2010-12-30
AU2008342910A1 (en) 2009-07-09
AR069966A1 (es) 2010-03-03
BRPI0821922A2 (pt) 2015-06-16
EP2238151A1 (de) 2010-10-13
JP2011507924A (ja) 2011-03-10
WO2009083266A1 (de) 2009-07-09
TW200940073A (en) 2009-10-01
CO6300845A2 (es) 2011-07-21
CA2710491A1 (en) 2009-07-09
ECSP10010318A (es) 2010-08-31
DOP2010000198A (es) 2010-08-31
DE102007063503A1 (de) 2009-07-02
CR11545A (es) 2010-08-27
US8937058B2 (en) 2015-01-20
UY31584A1 (es) 2009-08-03
JP5600068B2 (ja) 2014-10-01
KR20100102688A (ko) 2010-09-24
US20110021472A1 (en) 2011-01-27
CL2008003918A1 (es) 2010-01-15
CA2710491C (en) 2015-11-03
ZA201005396B (en) 2012-01-25

Similar Documents

Publication Publication Date Title
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
MX2009006756A (es) Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv.
ZA201002690B (en) N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
PA8848201A1 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
ECSP088972A (es) Isoindoles sustituidos como inhibidores de bace y su uso
UY33564A (es) 2-arilamino-5-aminocarbonil-benzimidazoles novedosos
AR078157A1 (es) Derivados de pirazol-[4,5-d]pirrolo[2,3-b]piridina inhibidores de tirosinquinasas jak 2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
UY28877A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida y composiciones
PE20070517A1 (es) Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
ATE473221T1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
PE20170084A1 (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4-9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparacion
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
TN2010000038A1 (en) Organic compounds
MX2012006026A (es) Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus.
PE20070491A1 (es) Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
AR071721A1 (es) Derivados de piridil-prolinamida, composiciones farmaceuticas que los contienen y su uso para el tratamiento de ansiedad, depresion y trastornos del sueno.

Legal Events

Date Code Title Description
FD Application declared void or lapsed